ASTELLAS PHARMA Valuation
| YPHA Stock | EUR 9.35 0.05 0.54% |
At this time, the firm appears to be overvalued. ASTELLAS PHARMA UNSPADR shows a prevailing Real Value of €8.21 per share. The current price of the firm is €9.35. Our model approximates the value of ASTELLAS PHARMA UNSPADR from analyzing the firm fundamentals such as return on equity of 0.0971, and Profit Margin of 0.11 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ASTELLAS PHARMA's price fluctuation is not too volatile at this time. Calculation of the real value of ASTELLAS PHARMA UNSPADR is based on 3 months time horizon. Increasing ASTELLAS PHARMA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ASTELLAS stock is determined by what a typical buyer is willing to pay for full or partial control of ASTELLAS PHARMA UNSPADR. Since ASTELLAS PHARMA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ASTELLAS Stock. However, ASTELLAS PHARMA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.35 | Real 8.21 | Hype 9.35 | Naive 9.35 |
The real value of ASTELLAS Stock, also known as its intrinsic value, is the underlying worth of ASTELLAS PHARMA UNSPADR Company, which is reflected in its stock price. It is based on ASTELLAS PHARMA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ASTELLAS PHARMA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ASTELLAS PHARMA UNSPADR helps investors to forecast how ASTELLAS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ASTELLAS PHARMA more accurately as focusing exclusively on ASTELLAS PHARMA's fundamentals will not take into account other important factors: ASTELLAS PHARMA Total Value Analysis
ASTELLAS PHARMA UNSPADR is at this time forecasted to have takeover price of 0 with market capitalization of 24.49 B, debt of 308 M, and cash on hands of 305.99 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ASTELLAS PHARMA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 24.49 B | 308 M | 305.99 B |
ASTELLAS PHARMA Investor Information
The company last dividend was issued on the 29th of September 2022. Based on the key measurements obtained from ASTELLAS PHARMA's financial statements, ASTELLAS PHARMA UNSPADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.ASTELLAS PHARMA Asset Utilization
One of the ways to look at asset utilization of ASTELLAS is to check how much profit was generated for every dollar of assets it reports. ASTELLAS PHARMA UNSPADR utilizes its assets nearly 0.0635 percent, making 0.0635 cents for each euro of assets held by the firm. An expanding asset utilization signifies that the company is being more competent with each euro of assets it shows. Put another way, asset utilization of ASTELLAS PHARMA shows how competent it operates for each euro spent on its assets.ASTELLAS PHARMA Profitability Analysis
The company reported the revenue of 1.41 T. Net Income was 100.86 B with profit before overhead, payroll, taxes, and interest of 1.04 T.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ASTELLAS PHARMA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ASTELLAS PHARMA and how it compares across the competition.
About ASTELLAS PHARMA Valuation
The stock valuation mechanism determines ASTELLAS PHARMA's current worth on a weekly basis. Our valuation model uses a comparative analysis of ASTELLAS PHARMA. We calculate exposure to ASTELLAS PHARMA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ASTELLAS PHARMA's related companies.Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15455 people.
8 Steps to conduct ASTELLAS PHARMA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ASTELLAS PHARMA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ASTELLAS PHARMA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ASTELLAS PHARMA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ASTELLAS PHARMA's revenue streams: Identify ASTELLAS PHARMA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ASTELLAS PHARMA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ASTELLAS PHARMA's growth potential: Evaluate ASTELLAS PHARMA's management, business model, and growth potential.
- Determine ASTELLAS PHARMA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ASTELLAS PHARMA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ASTELLAS Stock analysis
When running ASTELLAS PHARMA's price analysis, check to measure ASTELLAS PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ASTELLAS PHARMA is operating at the current time. Most of ASTELLAS PHARMA's value examination focuses on studying past and present price action to predict the probability of ASTELLAS PHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ASTELLAS PHARMA's price. Additionally, you may evaluate how the addition of ASTELLAS PHARMA to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |